Silobreaker.com    Log In
   My Page    Help   
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 10:34 PM

TVM Capital GmbH

Type: Company
Name: TVM Capital GmbH
First Reported 11/02/2009 - Updated 11/02/2009 - 2 Documents (in Health)
Probiodrug gains $54M to back Alzheimer's program
The early-stage German biotech Probiodrug AG won an impressive $54 million in fresh venture capital backing in one of the largest biotech rounds reported this year. The second round was led by BB Biotech and Edmond de Rothschild Investment Partners with ... [FierceBiotech - 11/02/2009]
First Reported 11/05/2009 - Updated 11/05/2009 - 1 Documents (in Internet & IT)
Bitwave dips into debt funding for $1.3M
BitWave Semiconductor Inc., a Lowell-based maker of a programmable wireless chip, has taken on $1.3 million from a planned $6 million debt funding round, according to federal documents.A recent filing with the U.S. Securities and Exchange commission indicated ... [Mass High Tech - 11/05/2009]
First Reported 11/06/2009 - Updated 11/06/2009 - 1 Documents (in Internet & IT)
Bitwave Raises $1.3M of $6M Round
IT , deals , VC Wade Roush wrote:Bitwave Semiconductor of Chelmsford, MA, has raised $1.33 million out of a planned $6 million Series C equity funding round, according to regulatory documents . The company makes radio-frequency integrated circuits for ... [Xconomy - 11/06/2009]
First Reported 10/22/2009 - Updated 10/22/2009 - 1 Documents (in Biology)
NC-based Argos Therapeutics reports good results on HIV drug trial
Argos Therapeutics reported positive Phase II clinical trial results of its individualized HIV treatment at the AIDS Vaccine 2009 Conference.The company said its AGS-004 had "unprecedented results" for its immunotherapy. The company plans additional Phase ... [TechJournal South - 10/22/2009]
First Reported 10/15/2009 - Updated 10/15/2009 - 1 Documents
Stem Cells USA & Regenerative Medicine Congress 2009
Washington D.C., USAStem Cells USA & Regenerative Medicine Congress will explore the scientific and business aspect of this rapidly growing market. Industry experts will cover all the main topics - discovery and development of stem cells, potential applications, ... [Pharmalicensing - 10/15/2009]
First Reported 10/20/2009 - Updated 10/20/2009 - 1 Documents (in Corporate Deals)
Top 10 (+ 1) New England Venture Deals of Q3 2009
VC , deals , startups Robert Buderi wrote:Weve brought you a lot of third-quarter venture data in the last week or soand were not done yet (hint: I have something special coming up for you baseball fans). But we havent gotten around to our usual Top ... [Xconomy - 10/20/2009]

More Content

All (26) | News (22) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (0)
sort by: Date | Relevance
Cosmo Pharmaceuticals offers to acquire BioXell [PipelineReview - 11/19/2009]
Biotech Cosmo Pharmaceuticals S.p.A. Aims to Bu... [BioSpace - 11/18/2009]
Albireo Announces Positive Clinical Data on A33... [Yahoo! Canada - 11/18/2009]
BioXell Supports Planned Acquisition by Cosmo P... [HUGIN Online - 11/18/2009]
BitWave Semiconductor Deploys Complete Berkeley... [Semiconductor Online - 11/13/2009]
Arteris Debuts FlexNoC, FlexWay Packages On-Chi... [EDA Geek - 11/10/2009]
Arteris Enhances Network-on-Chip Offerings to A... [Earthtimes.org - 11/09/2009]
Arteris Enhances Network-on-Chip Offerings to A... [Business Wire - 11/09/2009]
Bitwave Raises $1.3M of $6M Round [Xconomy - 11/06/2009]
Bitwave dips into debt funding for $1.3M [Mass High Tech - 11/05/2009]
Long-term Outcomes Data Validates the Utility o... [Street Insider - 11/04/2009]
BitWave Semiconductor Deploys Complete Berkeley... [Business Wire - 11/03/2009]
Probiodrug AG Closes Series B Financing Round E... [BioSpace - 11/02/2009]
Probiodrug gains $54M to back Alzheimer's program [FierceBiotech - 11/02/2009]
NOXXON Announces Initiation of First-in-Human C... [Yahoo! Canada - 11/02/2009]
Alzheimers treatment developer Probiodrug raises [AltAssets.net - 11/02/2009]
NOXXON Announces Initiation of First-in-Human C... [Forbes.com - 11/02/2009]
NC-based Argos Therapeutics reports good result... [TechJournal South - 10/22/2009]
Top 10 (+ 1) New England Venture Deals of Q3 2009 [Xconomy - 10/20/2009]
Stem Cells USA & Regenerative Medicine Cong... [Pharmalicensing - 10/15/2009]
NOXXON Pharma AG Announces Excellent Preliminar... [Yahoo! Canada - 10/13/2009]
NOXXON Pharma AG gibt exzellente erste Ergebnis... [FinanzNachrichten.de - 10/12/2009]
1
In Focus
  •  
Andrew Thomson, Robert Buderi, Jean-Pierre Routy, [more]
  •  
Ubidyne GmbH, Argos Therapeutics Inc, BB Biotech AG, [more]
  •  
Oregon Department of Energy, US Department of Energy, Duke University, [more]
  •  
Alzheimer's Disease, Zinc-Air Battery, Clean Technology, [more]
  •  
Cambridge (Massachusetts, United States), Portland (Oregon, United States), Lainate (Italy), [more]
  •  
Norway, England, United States, [more]
  •  
Internet & IT, Medicine, Venture Capital, [more]
  •  
Pharma & Biotech, IT, Health, [more]
Xconomy, Yahoo! Canada, Green Car Congress, [more]
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Zinc-Air Battery Company ReVolt Applying for $3... [Green Car Congress - 09/01/2009]
ReVolt Technology, LLC, a spin-off from Norway’s SINTEF that is developing rechargeable zinc-air batteries (earlier post), is applying for $30 million in grants ...
Wireless player Ubidyne wins $14.4 million Seri... [TechCrunch Europe - 08/20/2009]
If the future is highly mobile oriented then the people who make the antenna that power this wireless world are in a powerful position. Which is why it’s perhaps ...
ReVolt Technology and BASF in Joint Development... [Green Car Congress - 07/09/2009]
Energy densities of different battery technologies. Source: ReVolt. Click to enlarge.ReVolt Technology Ltd, a technology company which has developed a rechargeable ...
European cleantech feels the pinch — looks to d... [Venturebeat - 04/29/2009]
European cleantech is finally feeling the funding crunch. Market analysts at the Cleantech Group released a report today showing that investment in the sector during ...
1

  •  
  •  
  •